Tether 斥资 2 亿美元推进脑机接口

领先的稳定币发行商 Tether 进行了 2 亿美元的战略投资，收购了领先的脑机接口公司 Blackrock Neurotech 的多数股权。这项投资由 Tether Evo 牵头，旨在支持 Blackrock Neurotech 突破性医疗设备的开发和商业化，重点帮助受瘫痪和神经系统疾病影响的个人。

Tether Invests $200 Million in Blackrock Neurotech to Advance Brain-Computer Interface Technologies

Tether 向 Blackrock Neurotech 投资 2 亿美元，以推进脑机接口技术

Tether, the issuer of the leading stablecoin USDT, has announced a substantial investment of $200 million to acquire a majority stake in Blackrock Neurotech, a pioneering company specializing in brain-computer interface (BCI) technology.

领先的稳定币 USDT 发行人 Tether 宣布斥资 2 亿美元收购 Blackrock Neurotech 的多数股权，Blackrock Neurotech 是一家专注于脑机接口（BCI）技术的先驱公司。

This strategic investment, made through Tether's venture capital arm, Tether Evo, reflects the company's commitment to supporting the development and commercialization of Blackrock Neurotech's innovative medical devices.

这项战略投资是通过 Tether 的风险投资部门 Tether Evo 进行的，反映了该公司对支持 Blackrock Neurotech 创新医疗设备的开发和商业化的承诺。

Blackrock Neurotech is renowned for its expertise in creating medical devices that utilize brain signals, offering hope to individuals affected by paralysis and other neurological disorders. It is important to note that Blackrock Neurotech is distinct from the asset management giant BlackRock.

Blackrock Neurotech 以其在制造利用大脑信号的医疗设备方面的专业知识而闻名，为遭受瘫痪和其他神经系统疾病影响的个人带来了希望。值得注意的是，Blackrock Neurotech 与资产管理巨头 BlackRock 不同。

The capital infusion from Tether will enable Blackrock Neurotech to expand its operations, including the deployment and market entry of its groundbreaking medical devices. The funds will also support ongoing research and development initiatives to further enhance the company's technology portfolio.

Tether 的注资将使 Blackrock Neurotech 能够扩大其业务，包括其突破性医疗设备的部署和市场进入。这些资金还将支持正在进行的研究和开发计划，以进一步增强公司的技术组合。

With a market capitalization of $110 billion, Tether dominates the stablecoin market. In recent years, the company has expanded its interests by establishing four distinct business units beyond stablecoin issuance.

Tether 市值 1100 亿美元，在稳定币市场占据主导地位。近年来，该公司通过在稳定币发行之外建立四个不同的业务部门来扩大其业务范围。

Paolo Ardoino, CEO of Tether, stated the company's unwavering commitment to investing in emerging technologies with the potential to transform society. He expressed particular enthusiasm for Blackrock Neurotech's BCI technology, highlighting its ability to revolutionize communication, rehabilitation, and cognitive enhancement.

Tether 首席执行官 Paolo Ardoino 表示，该公司坚定不移地致力于投资具有改变社会潜力的新兴技术。他对 Blackrock Neurotech 的 BCI 技术表达了特别的热情，强调了其彻底改变沟通、康复和认知增强的能力。

"We are excited to partner with Blackrock Neurotech and support their mission of developing life-changing medical devices," Ardoino said. "We believe that their BCI technology has the potential to unlock new possibilities for individuals living with neurological challenges."

Ardoino 表示：“我们很高兴与 Blackrock Neurotech 合作，支持他们开发改变生活的医疗设备的使命。” “我们相信他们的脑机接口技术有潜力为患有神经系统疾病的个体带来新的可能性。”

Blackrock Neurotech's technology leverages cutting-edge neural interfaces to bridge the gap between the brain and external devices. By translating brain signals into commands, BCI systems enable individuals with limited mobility or speech difficulties to communicate, control computers, and even operate robotic limbs.

Blackrock Neurotech 的技术利用尖端的神经接口来弥合大脑和外部设备之间的差距。通过将大脑信号转化为命令，脑机接口系统使行动不便或言语困难的个人能够进行交流、控制计算机，甚至操作机器人肢体。

The investment in Blackrock Neurotech aligns with Tether's broader commitment to fostering technological innovation and supporting companies that are addressing real-world challenges. Tether Evo serves as a catalyst for the company's diversification efforts, enabling it to invest in promising ventures that have the potential to drive growth and make a positive impact on society.

对 Blackrock Neurotech 的投资符合 Tether 对促进技术创新和支持应对现实世界挑战的公司的更广泛承诺。 Tether Evo 是公司多元化努力的催化剂，使其能够投资于有潜力推动增长并对社会产生积极影响的有前途的企业。